Pharmaniaga Berhad reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was MYR 789.81 million compared to MYR 862.72 million a year ago. Net loss was MYR 32.72 million compared to MYR 644.39 million a year ago. Basic loss per share from continuing operations was MYR 0.0239 compared to MYR 0.4919 a year ago. Diluted loss per share from continuing operations was MYR 0.0239 compared to MYR 0.4919 a year ago.
For the full year, sales was MYR 3,404.48 million compared to MYR 3,480.94 million a year ago. Net loss was MYR 77.45 million compared to MYR 629.92 million a year ago. Basic loss per share from continuing operations was MYR 0.0566 compared to MYR 0.4809 a year ago. Diluted loss per share from continuing operations was MYR 0.0566 compared to MYR 0.4809 a year ago.